← Back to Search

Behavioral Intervention for Opioid Use Disorder (HOPE MOUD Trial)

N/A
Waitlist Available
Led By Sean D Young, PhD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Is not currently prescribed MOUD
English speakers only
Timeline
Screening 3 weeks
Treatment Varies
Follow Up request during the course of the 12-week community
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing an intervention to get people with opioid addiction to use medication-assisted treatment, and will follow up with them for 1 year.

Who is the study for?
This trial is for adults over 18 living in CA, NV, AZ, OR, WA with moderate to severe opioid use disorder who use social media at least twice a week. Participants must speak English and be willing to create or have a Facebook/social media account to engage with the study's online support group.
What is being tested?
The HOPE intervention is being tested for its effectiveness in encouraging patients with opioid use disorder to start taking medications designed to treat their condition. The study will follow participants for up to one year and analyze data from an online community.
What are the potential side effects?
Since this trial involves a behavioral intervention rather than medication, traditional side effects are not expected. However, participants may experience emotional or psychological responses due to engagement with the online support program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not currently taking medication for opioid use disorder.
Select...
I speak English.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~request during the course of the 12-week community
This trial's timeline: 3 weeks for screening, Varies for treatment, and request during the course of the 12-week community for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of requests to receive a resource on medications that can be used to treat opioid use disorder

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
HOPE intervention peer-led online community
Group II: ControlActive Control1 Intervention
Online community without HOPE intervention psychological components
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HOPE
2010
Completed Phase 1
~1740

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,158,992 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
853 Previous Clinical Trials
671,100 Total Patients Enrolled
University of California, IrvineLead Sponsor
560 Previous Clinical Trials
1,929,462 Total Patients Enrolled

Media Library

HOPE Online Support Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04712981 — N/A
Opioid Use Disorder Research Study Groups: Intervention, Control
Opioid Use Disorder Clinical Trial 2023: HOPE Online Support Intervention Highlights & Side Effects. Trial Name: NCT04712981 — N/A
HOPE Online Support Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04712981 — N/A
~90 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top